Cargando…

Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.

Introduction: Cardiovascular diseases (CVDs) are the leading cause of death in India. The CVD risk approach is a cost-effective way to identify those at high risk, especially in a low resource setting. As there is no validated prognostic model for an Indian urban population, we have re-calibrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Priti, Prieto-Merino, David, Ajay, Vamadevan S., Singh, Kalpana, Roy, Ambuj, Krishnan, Anand, Narayan, K.M. Venkat, Ali, Mohammed K., Tandon, Nikhil, Prabhakaran, Dorairaj, Perel, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255911/
https://www.ncbi.nlm.nih.gov/pubmed/32518840
http://dx.doi.org/10.12688/wellcomeopenres.15137.2
_version_ 1783539816079556608
author Gupta, Priti
Prieto-Merino, David
Ajay, Vamadevan S.
Singh, Kalpana
Roy, Ambuj
Krishnan, Anand
Narayan, K.M. Venkat
Ali, Mohammed K.
Tandon, Nikhil
Prabhakaran, Dorairaj
Perel, Pablo
author_facet Gupta, Priti
Prieto-Merino, David
Ajay, Vamadevan S.
Singh, Kalpana
Roy, Ambuj
Krishnan, Anand
Narayan, K.M. Venkat
Ali, Mohammed K.
Tandon, Nikhil
Prabhakaran, Dorairaj
Perel, Pablo
author_sort Gupta, Priti
collection PubMed
description Introduction: Cardiovascular diseases (CVDs) are the leading cause of death in India. The CVD risk approach is a cost-effective way to identify those at high risk, especially in a low resource setting. As there is no validated prognostic model for an Indian urban population, we have re-calibrated the original Framingham model using data from two urban Indian studies. Methods: We have estimated three risk score equations using three different models. The first model was based on Framingham original model; the second and third are the recalibrated models using risk factor prevalence from CARRS (Centre for cArdiometabolic Risk Reduction in South-Asia) and ICMR (Indian Council of Medical Research) studies, and estimated survival from WHO 2012 data for India. We applied these three risk scores to the CARRS and ICMR participants and estimated the proportion of those at high-risk (>30% 10 years CVD risk) who would be eligible to receive preventive treatment such as statins. Results: In the CARRS study, the proportion of men with 10 years CVD risk > 30% (and therefore eligible for statin treatment) was 13.3%, 21%, and 13.6% using Framingham, CARRS and ICMR risk models, respectively. The corresponding proportions of women were 3.5%, 16.4%, and 11.6%. In the ICMR study the corresponding proportions of men were 16.3%, 24.2%, and 16.5% and for women, these were 5.6%, 20.5%, and 15.3%. Conclusion: Although the recalibrated model based on local population can improve the validity of CVD risk scores our study exemplifies the variation between recalibrated models using different data from the same country. Considering the growing burden of cardiovascular diseases in India, and the impact that the risk approach has on influencing cardiovascular prevention treatment, such as statins, it is essential to develop high quality and well powered local cohorts (with outcome data) to develop local prognostic models.
format Online
Article
Text
id pubmed-7255911
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-72559112020-06-08 Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations. Gupta, Priti Prieto-Merino, David Ajay, Vamadevan S. Singh, Kalpana Roy, Ambuj Krishnan, Anand Narayan, K.M. Venkat Ali, Mohammed K. Tandon, Nikhil Prabhakaran, Dorairaj Perel, Pablo Wellcome Open Res Research Article Introduction: Cardiovascular diseases (CVDs) are the leading cause of death in India. The CVD risk approach is a cost-effective way to identify those at high risk, especially in a low resource setting. As there is no validated prognostic model for an Indian urban population, we have re-calibrated the original Framingham model using data from two urban Indian studies. Methods: We have estimated three risk score equations using three different models. The first model was based on Framingham original model; the second and third are the recalibrated models using risk factor prevalence from CARRS (Centre for cArdiometabolic Risk Reduction in South-Asia) and ICMR (Indian Council of Medical Research) studies, and estimated survival from WHO 2012 data for India. We applied these three risk scores to the CARRS and ICMR participants and estimated the proportion of those at high-risk (>30% 10 years CVD risk) who would be eligible to receive preventive treatment such as statins. Results: In the CARRS study, the proportion of men with 10 years CVD risk > 30% (and therefore eligible for statin treatment) was 13.3%, 21%, and 13.6% using Framingham, CARRS and ICMR risk models, respectively. The corresponding proportions of women were 3.5%, 16.4%, and 11.6%. In the ICMR study the corresponding proportions of men were 16.3%, 24.2%, and 16.5% and for women, these were 5.6%, 20.5%, and 15.3%. Conclusion: Although the recalibrated model based on local population can improve the validity of CVD risk scores our study exemplifies the variation between recalibrated models using different data from the same country. Considering the growing burden of cardiovascular diseases in India, and the impact that the risk approach has on influencing cardiovascular prevention treatment, such as statins, it is essential to develop high quality and well powered local cohorts (with outcome data) to develop local prognostic models. F1000 Research Limited 2019-12-02 /pmc/articles/PMC7255911/ /pubmed/32518840 http://dx.doi.org/10.12688/wellcomeopenres.15137.2 Text en Copyright: © 2019 Gupta P et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gupta, Priti
Prieto-Merino, David
Ajay, Vamadevan S.
Singh, Kalpana
Roy, Ambuj
Krishnan, Anand
Narayan, K.M. Venkat
Ali, Mohammed K.
Tandon, Nikhil
Prabhakaran, Dorairaj
Perel, Pablo
Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
title Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
title_full Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
title_fullStr Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
title_full_unstemmed Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
title_short Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
title_sort cardiovascular risk prediction in india: comparison of the original and recalibrated framingham prognostic models in urban populations.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255911/
https://www.ncbi.nlm.nih.gov/pubmed/32518840
http://dx.doi.org/10.12688/wellcomeopenres.15137.2
work_keys_str_mv AT guptapriti cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT prietomerinodavid cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT ajayvamadevans cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT singhkalpana cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT royambuj cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT krishnananand cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT narayankmvenkat cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT alimohammedk cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT tandonnikhil cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT prabhakarandorairaj cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations
AT perelpablo cardiovascularriskpredictioninindiacomparisonoftheoriginalandrecalibratedframinghamprognosticmodelsinurbanpopulations